Effect of melphalan dose adjustment in multiple myeloma patients undergoing autologous stem cell transplantation

被引：0
|
作者：
Gonzalez, A. P. [1 ]
Gonzalez, A. J. [1 ]
Palomo, P. [1 ]
Fernandez, R. [1 ]
Pardo, C. [1 ]
Alarcon, C. [1 ]
Fonseca, A. [1 ]
Fonseca, A. [1 ]
Gonzalez, S. [1 ]
Rayon, C. [1 ]
Vallejo, C. [1 ]
机构：
[1] Univ Cent Hosp Asturias, Oviedo, Spain
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S228 / S229
页数：2
相关论文
共 50 条
  • [21] Impact of infused lymphocyte dose on the outcome of patients with multiple myeloma undergoing autologous stem cell transplantation
    Symeonidis, A.
    Ings, S.
    Rabin, N.
    Watts, M.
    D'Sa, S.
    Linch, D.
    Yong, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 188 - 189
  • [22] Melphalan Dose in Myeloma Patients over 65 Years of Age Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation
    Ghilardi, Guido
    Pabst, Thomas
    Jeker, Barbara
    Mueller, Rouven
    Cairoli, Anne
    Mueller, Antonia
    Bargetzi, Mario
    Hitz, Felicitas
    Baldomero, Helen
    Heim, Dominik
    Rossi, Davide
    Ghielmini, Michele
    Lerch, Erika
    Schanz, Urs
    Passweg, Jakob R.
    Stussi, Georg
    Kleber, Martina
    Gerber, Bernhard
    BLOOD, 2017, 130
  • [23] Individualized high dose busulfan in patients undergoing autologous stem cell transplantation for multiple myeloma.
    Clopés, A
    Sureda, A
    Brunet, S
    Altés, A
    Martino, R
    Paladio, N
    Queraltó, JM
    Mangues, MA
    Sierra, J
    BLOOD, 2001, 98 (11) : 201A - 201A
  • [24] Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation
    A C Sherman
    S Simonton
    U Latif
    R Spohn
    G Tricot
    Bone Marrow Transplantation, 2004, 33 : 955 - 962
  • [25] Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation
    Sherman, AC
    Simonton, S
    Latif, U
    Spohn, R
    Tricot, G
    BONE MARROW TRANSPLANTATION, 2004, 33 (09) : 955 - 962
  • [26] Changes in Quality-of-Life and Psychosocial Adjustment among Multiple Myeloma Patients Treated with High-Dose Melphalan and Autologous Stem Cell Transplantation
    Sherman, Allen C.
    Simonton, Stephanie
    Latif, Umaira
    Plante, Thomas G.
    Anaissie, Elias J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (01) : 12 - 20
  • [27] TIMING OF HIGH DOSE MELPHALAN (HDM) AND OUTCOMES FOR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH MULTIPLE MYELOMA (MM)
    Mahindra, A.
    Bolwell, B.
    Rybicki, L.
    Sobecks, R.
    Pohlman, B.
    Andresen, S.
    Earl, M.
    Dean, R.
    Copelan, E.
    Kalaycio, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 41 - 42
  • [28] Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation
    Chitre, Sneha
    Stoelzel, Friedrich
    Cuthill, Kirsty
    Streetly, Mathew
    Graham, Charlotte
    Dill, Claudia
    Mohamedali, Azim
    Smith, Alexander
    Schetelig, Johannes
    Altmann, Heidi
    Bornhaeuser, Martin
    Mufti, Ghulam J.
    LEUKEMIA, 2018, 32 (09) : 2020 - 2024
  • [29] Outpatient management of patients with multiple myeloma undergoing autologous stem cell transplantation
    Palmieri, S
    Mele, G
    Copia, C
    Schiavone, EM
    Pocali, B
    Viola, A
    Graziano, D
    Alberti, M
    De Simone, M
    Damico, MR
    BONE MARROW TRANSPLANTATION, 2005, 35 : S187 - S187
  • [30] Clonal Hematopoiesis in patients with Multiple Myeloma undergoing Autologous Stem Cell Transplantation
    Chitre, S.
    Stoelzel, F.
    Cuthill, K.
    Streetly, M.
    Graham, C.
    Bornhauser, M.
    Mufti, G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 101 - 102
12345